P Wave Dispersion in Patients With Biomass Cxposure of the community la Cruz de Taratara, Sucre Municipality, Falcon State, During the Period January – May 2017
Keywords:
Atrial fibrillation, biomass, electrocardiogram, P wave dispersionAbstract
The risk of COPD is related to the total burden of inhaled particles to which an individual is exposed during his whole life, for example indoor air pollution as result from the burning of biomass fuels for cooking. Objective: To study P wave dispersion in patients with biomass exposure of the community La Cruz de Taratara, Sucre Municipality, Falcon State, during the period January – May 2017. Methods: In this observational case-control study, with analytical non-experimental design, 30 patients with biomass exposure were included (19 women and 11 men), mean age 65.4 ± 11.7 years; control group consisted of 10 patients without biomass exposure matched by same gender and age. Electrocardiograms were performed in all patients for P wave duration manual measurement in at least 7 of the 12 leads. Results: P wave dispersion was founds to be significantly higher in patients with biomass exposure in comparison to control cases (48.33 ± 9.12 ms versus 24 ± 5.16 ms) (p: ˂ 0.05). Conclusion: Patients with biomass exposure may have a higher likelihood of atrial arrhythmias, especially paroxysmal atrial fibrillation, due to prolonged PWD.
Downloads
References
Gaziano TA, Gaziano JM. Epidemiología de las Enfermedades Cardiovasculares. En Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL Loscalzo J, editores. Harrison: Principios de Medicina Interna, 18 ed. Nueva York: The McGraw Hill Companies, Inc. 2012. p. 1375-79.
Mont L, Brugada J. Arritmias Cardíacas. En Rozman C, Cardellach F, editores. Farreras-Rozman: Medicina Interna. 17 ed. Barcelona: Elseiver España, S.L.. p. 431-60.
Camm AJ et al. Guías de práctica clínica para el manejo de la fibrilación auricular. 2.ª edición. Rev Esp Cardiol. 2010; 63(12): 1483.e1-e83.
Hadid C, González JL, et al. Consenso de Fibrilación Auricular de la Sociedad Argentina de Cardiología. Revista Argentina de Cardiología, Volumen 83, Suplemento 1.
Marchlinski, F. Taquiarritmias. En Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL Loscalzo J, editores. Harrison: Principios de Medicina Interna, 18 ed. Nueva York: The McGraw Hill Companies, Inc. 2012. p. 1425-43.
Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-429.
Maisel W, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology and rationale for therapy. Am J Cardiol 2003; 91: 2D-9D.
Guindo J, Martínez MD, Durán I, Tomos P, Martínez-Rubio A. Evaluación de riesgo tromboembólico y hemorrágico de los pacientes con fibrilación auricular. Rev Esp Cardiol Supl. 2013; 13(C): 9-13.
Okutucu S, Aytemir K, Oto A. P-wave dispersion: What we know till now?. Journal of the Royal Society of Medicine Cardiovascular Disease 2016; 5: 1–9.
Dilaveris PE, Gialafos JE. P-Wave Dispersion: A Novel Predictor of Paroxysmal Atrial Fibrillation. A.N.E. 2001; 6(2): 159-165.
Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, Gialafos JE, Toutouzas PK. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998 May; 135(5 Pt 1): 733-8.
García M, Hurtado R, Llenas J, Cepeda J, García L, Pérez A, et al. Fibrilación Auricular en pacientes con EPOC: Prevalencia y Factores Asociados. Rev Clin Esp. 2015; 215 (Espec Congr): 990.
Decramer M, Vestbo J, Hui DS, Nishimura M, Stockley R, Bourbeau J, et al. Iniciativa Global para la Enfermedad Pulmonar Obstructiva Crónica. Global Iniciative for Chronic Obstructive Lungd Disease, Inc. 2014.
López M, Mongilardi N, Checkley W. Enfermedad pulmonar obstructiva crónica por exposición al humo de biomasa. Rev.perú.med.exp. salud pública. 2014; vol.31: no.1.
Torres-Duque CA, García-Rodriguez MC, González-García M. Enfermedad pulmonar obstructiva crónica por humo de leña: ¿un fenotipo diferente o una entidad distinta?. Arch.Bronconeumol. 2016; 52: 425-31.
Mann DL. Insuficiencia Cardíaca y Cor Pulmonale. En Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL Loscalzo J, editores. Harrison: Principios de Medicina Interna, 18 ed. Nueva York: The McGraw Hill Companies, Inc. 2012. p. 1443-55.
Yucel O, Yildiz M, Altınkaynak S, Sayan A. P-wave dispersion and P-wave duration in children with stable asthma bronchiale. Anadolu Kardiyol Derg 2009; 9: 118-22.
Liu T, Fu Z, Korantzopoulos P, Zhang X, Wang S, Li G. Effect of Obesity on P-Wave Parameters in a Chinese Population. Ann Noninvasive Electrocardiol. 2010; 15(3): 259-63.
Sahin M, Bilgili SG, Simsek H, Akdag S, Akyol A, Gumrukcuoglu HA, et al. Increased P-wave dispersion in patients with newly diagnosed lichen planus. Clinics. 2013; 68(6): 846-850.
Francia P, Ricotta A, Balla C, Adduci C, Semprini L, Frattari A. P-Wave Duration in Lead aVR and the Risk of Atrial Fibrillation in Hypertension. Ann Noninvasive Electrocardiol. 2015 Mar; 20(2): 167-74.
Dedeoglu E, Bayram B, Omu D, et al. The P-wave dispersion and QTC durations in the patients with acute pancreatitis. Acta Medica Mediterranea, 2014; 30: 869.
Mahmoud F, Mohamed F, editores. Guía Práctica de Investigación en Salud. Washington (DC): Organización Panamericana de la Salud. 2008.
Downloads
Published
How to Cite
Issue
Section
License
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
